Page last updated: 2024-10-26

brl 42810 and Cystic Fibrosis

brl 42810 has been researched along with Cystic Fibrosis in 1 studies

Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.

Research Excerpts

ExcerptRelevanceReference
"Lamivudine 3 mg/kg was administered on a compassionate-use basis for 14-36 months."1.31Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children. ( Bar-Nathan, N; Ben-Ari, Z; Dinari, G; Mor, E; Shapira, R; Sokal, EM; Tur-Kaspa, R, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shapira, R1
Mor, E1
Bar-Nathan, N1
Sokal, EM1
Tur-Kaspa, R1
Dinari, G1
Ben-Ari, Z1

Other Studies

1 other study available for brl 42810 and Cystic Fibrosis

ArticleYear
Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children.
    Transplantation, 2001, Jul-27, Volume: 72, Issue:2

    Topics: 2-Aminopurine; Adolescent; Alanine Transaminase; Antiviral Agents; Child; Child, Preschool; Cystic F

2001